Clinical Trial Update: NoAL (HPMC) in Combination With Oxymetazoline in Patients With Allergic Rhinitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating NoAL (HPMC) in combination with oxymetazoline for allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• NoAL (HPMC) (Hydroxypropyl methylcellulose)
• Oxymetazoline (oxymetazoline)

Snippet

Sponsor: Association Asthma, Bulgaria | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED